REFERENCES
- Raijmakers MTM, Dechend R, Poston L. Oxidative stress and preeclampsia. Rationale for antioxidant clinical trials. Hypertension 2004; 44: 374–379
- Redman CWG, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592–1594
- Borzychowski AM, Sargent IL, Redman CW. Inflammation and preeclampsia. Semin Fetal Neonatal Med 2006; 11: 309–316
- Redman CWG, Sargent IL. Preeclampsia, the placenta and the maternal systemic inflammatory response—a review. Placenta 2003; 24: S21–S27
- Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, et al. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44: 708–716
- Redman CWG, Sacks GP, Sargeant IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499–506
- Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol 2004; 190: 1177–1178
- Morris JM, Gopaul NK, Endresen M, JR, Knight M, Linton EA, Dhir S, et al. Circulating markers of oxidative stress are raised in normal pregnancy and preeclampsia. Br J Obstet Gynaecol 1998; 105: 1195–1199
- Wang Y, Walsh SW. Increased superoxide generation is associated with decreased superoxide dismutase activity and mRNA expression in placental trophoblast cells in preeclampsia. Placenta 2001; 22: 206–212
- Sankaralingam S, Arenas IA, Lalu MM, Davidge ST. Preeclampsia: current understanding of the molecular basis of vascular dysfunction. Expert Rev Mol Med 2006; 26: 1–20
- Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX–XIV
- Bodnar LM, Ness RB, Harger GF, Roberts JM. Inflammation and triglycerides partially mediate the effect of prepregnancy body mass index on the risk of preeclampsia. Am J Epidemiol 2005; 162: 1198–1206
- Walsh SW, Vaughan JE, Wang Y, Roberts J. Placental isoprostane is significantly increased in preeclampsia. FASEB J 2000; 14: 1289–1296
- O'Brien TE, Ray JG, Chan WS. Maternal body mass index and the risk of preeclampsia: a systematic overview. Epidemiology 2003; 14: 368–374
- Barden A, Beilin LJ, Ritchie J, croft KD, Walters BN, Michael CA. Plasma and urinary 8-isoprostane as an indicator of lipid peroxidation in preeclampsia and normal pregnancy. Clin Sci 1996; 91: 711–718
- Roberts JM, Hubel CA. Is oxidative stress the link in the two-stage model of preeclampsia?. Lancet 1999; 354: 788–789
- Harma M, Harma M, Erel O. Oxidative stress in women with preeclampsia. Am J Obstet Gynecol 2005; 192: 656–657
- Montuschi P, Barnes PJ, Roberts LJ. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004; 18: 1791–1800
- Aksoy H, Taysi S, Altinkaynak K, Bakan E, Bakan N, Kumtepe Y. Antioxidant potential and transferrin, ceruloplasmin and lipid peroxidation levels in women with preeclampsia. J Invest Med 2003; 51: 284–287
- Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005; 46: 1243
- Barden A, Ritchie J, Walters B, Michael C, Rivera J, Mori T, et al. Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia. Hypertension 2001; 38: 803–808
- Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86: 2505–2512
- Rinehart BK, Terrone DA, Lagoo-Deenadayalan S, Barber WH, Hale EA, Martin JNJ, et al. Expression of the placental cytokines tumor necrosis factor? interleukin 1ß, and interleukin 10 is increased in preeclampsia. Am J Obstet Gynecol 1999; 181: 915–920
- Teran E, Escudero C, Calle A. C-reactive protein during normal pregnancy and preeclampsia. Int J Gynecol Obstet 2005; 89: 299–300